(redirected from Vaginal ring)
Also found in: Dictionary, Thesaurus, Medical, Financial, Encyclopedia, Wikipedia.
Related to Vaginal ring: intrauterine device, IUD, NuvaRing
References in periodicals archive ?
However, work on the dedicated extended-use product Seasonale marks the start of a rigorous research process, and the near future will probably bring the study of extended patch and vaginal ring usage.
O-14] Impact of Luteal Supplementation with a Weekly Progesterone Vaginal Ring During In Vitro Fertilization (IVF) by Day of Embryo Transfer (ET) (Oral Session: Clinical Female Infertility and Gynecology: Monday, October 22, 2012: 6:00 - 6:15 p.
Country mapping: Senegal," Progesterone Vaginal Ring Technical Report.
Long-acting contraceptive methods--intrauterine devices and subdermal implants--were superior to oral contraceptives, transdermal patches, and vaginal rings in preventing unintended pregnancies, results from a prospective study of more than 7,000 at-risk women show.
1) The NuvaRing is a vaginal ring worn for 3 consecutive weeks in a 4-week cycle.
SAN DIEGO - The risk of venous thromboembolism in women using an etonogestrel-containing vaginal ring did not differ significantly from the risk in women on combined oral contraceptives over a 4-year period, a prospective cohort study of 33,704 women found.
Depot medroxyprogesterone acetate (DMPA; Depo-Provera) and the combination contraceptive vaginal ring (NuvaRing) are most effective for obese women because they don't appear to be affected by body weight (strength of recommendation [SOR]: B, consistent cohort studies).
Implanon works primarily by suppressing ovulation, but it also thickens cervical mucus, a secondary mechanism, according to Organon, which also markets NuvaRing, the vaginal ring that contains etonogestrel and estrogen.
Femring (estradiol, extended release) by Warner Chilcott and Estring (estradiol acetate, extended release) by Pfizer are types of vaginal ring.
This new edition includes information about available and new methods, including the LNG-IUD and implants, long-acting reversible methods; subcutaneous depot medroxyprogesterone acetate (DMPA-SC), with the potential for self-injection; and the new progesterone-releasing vaginal ring for breastfeeding women.
Critical health company The Population Council said on Wednesday that it has successfully submitted its one-year Nestorone/ethinyl estradiol vaginal ring for pregnancy prevention for review with the US Food and Drug Administration (FDA).